vs
LivaNova PLC（LIVN）与Revolve Group, Inc.（RVLV）财务数据对比。点击上方公司名可切换其他公司
LivaNova PLC的季度营收约是Revolve Group, Inc.的1.1倍（$360.9M vs $324.4M），LivaNova PLC净利率更高（8.6% vs 5.7%，领先2.8%），LivaNova PLC同比增速更快（12.1% vs 10.4%），LivaNova PLC自由现金流更多（$50.2M vs $-13.3M），过去两年LivaNova PLC的营收复合增速更高（10.6% vs 9.5%）
LivaNova PLC是一家深耕医疗设备领域的企业，总部位于英国，核心业务为研发心脏外科及神经调控类医疗设备。该公司由美国Cyberonics公司与意大利Sorin公司于2015年以27亿美元对价合并成立，目前在纳斯达克挂牌交易，股票代码为LIVN。
Revolve Theatre Company是总部位于英国泰晤士河畔亨利的剧团，专注于创作演出政治题材和莎士比亚系列戏剧作品，由奥利弗·登奇、乔·莫里斯与汤姆·史密斯共同创立运营。
LIVN vs RVLV — 直观对比
营收规模更大
LIVN
是对方的1.1倍
$324.4M
营收增速更快
LIVN
高出1.7%
10.4%
净利率更高
LIVN
高出2.8%
5.7%
自由现金流更多
LIVN
多$63.5M
$-13.3M
两年增速更快
LIVN
近两年复合增速
9.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $360.9M | $324.4M |
| 净利润 | $30.9M | $18.6M |
| 毛利率 | 65.2% | 53.3% |
| 营业利润率 | 11.8% | 6.3% |
| 净利率 | 8.6% | 5.7% |
| 营收同比 | 12.1% | 10.4% |
| 净利润同比 | -44.7% | 50.4% |
| 每股收益（稀释后） | $0.57 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LIVNRVLV
| Q4 25 | $360.9M | $324.4M | ||
| Q3 25 | $357.8M | $295.6M | ||
| Q2 25 | $352.5M | $309.0M | ||
| Q1 25 | $316.9M | $296.7M | ||
| Q4 24 | $321.8M | $293.7M | ||
| Q3 24 | $318.1M | $283.1M | ||
| Q2 24 | $318.6M | $282.5M | ||
| Q1 24 | $294.9M | $270.6M |
净利润LIVNRVLV
| Q4 25 | $30.9M | $18.6M | ||
| Q3 25 | $26.8M | $21.2M | ||
| Q2 25 | $27.2M | $10.2M | ||
| Q1 25 | $-327.3M | $11.8M | ||
| Q4 24 | $55.9M | $12.3M | ||
| Q3 24 | $33.0M | $11.0M | ||
| Q2 24 | $16.3M | $15.4M | ||
| Q1 24 | $-41.9M | $10.9M |
毛利率LIVNRVLV
| Q4 25 | 65.2% | 53.3% | ||
| Q3 25 | 68.4% | 54.6% | ||
| Q2 25 | 67.8% | 54.1% | ||
| Q1 25 | 69.7% | 52.0% | ||
| Q4 24 | 68.2% | 52.5% | ||
| Q3 24 | 70.8% | 51.2% | ||
| Q2 24 | 68.7% | 54.0% | ||
| Q1 24 | 70.3% | 52.3% |
营业利润率LIVNRVLV
| Q4 25 | 11.8% | 6.3% | ||
| Q3 25 | 15.1% | 7.1% | ||
| Q2 25 | 15.4% | 5.8% | ||
| Q1 25 | 15.3% | 5.0% | ||
| Q4 24 | 11.5% | 3.9% | ||
| Q3 24 | 11.2% | 5.0% | ||
| Q2 24 | 12.6% | 5.8% | ||
| Q1 24 | 5.5% | 3.4% |
净利率LIVNRVLV
| Q4 25 | 8.6% | 5.7% | ||
| Q3 25 | 7.5% | 7.2% | ||
| Q2 25 | 7.7% | 3.3% | ||
| Q1 25 | -103.3% | 4.0% | ||
| Q4 24 | 17.4% | 4.2% | ||
| Q3 24 | 10.4% | 3.9% | ||
| Q2 24 | 5.1% | 5.4% | ||
| Q1 24 | -14.2% | 4.0% |
每股收益（稀释后）LIVNRVLV
| Q4 25 | $0.57 | $0.27 | ||
| Q3 25 | $0.49 | $0.29 | ||
| Q2 25 | $0.50 | $0.14 | ||
| Q1 25 | $-6.01 | $0.16 | ||
| Q4 24 | $1.04 | $0.18 | ||
| Q3 24 | $0.60 | $0.15 | ||
| Q2 24 | $0.30 | $0.21 | ||
| Q1 24 | $-0.78 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $635.6M | $292.3M |
| 总债务越低越好 | $376.1M | — |
| 股东权益账面价值 | $1.2B | $512.5M |
| 总资产 | $2.6B | $765.0M |
| 负债/权益比越低杠杆越低 | 0.31× | — |
8季度趋势，按日历期对齐
现金及短期投资LIVNRVLV
| Q4 25 | $635.6M | $292.3M | ||
| Q3 25 | $646.1M | $315.4M | ||
| Q2 25 | $593.6M | $310.7M | ||
| Q1 25 | $738.4M | $300.8M | ||
| Q4 24 | $428.9M | $256.6M | ||
| Q3 24 | $346.4M | $252.8M | ||
| Q2 24 | $329.2M | $244.7M | ||
| Q1 24 | $309.2M | $273.4M |
总债务LIVNRVLV
| Q4 25 | $376.1M | — | ||
| Q3 25 | $434.5M | — | ||
| Q2 25 | $430.6M | — | ||
| Q1 25 | $628.2M | — | ||
| Q4 24 | $627.0M | — | ||
| Q3 24 | $625.5M | — | ||
| Q2 24 | $624.5M | — | ||
| Q1 24 | $623.8M | — |
股东权益LIVNRVLV
| Q4 25 | $1.2B | $512.5M | ||
| Q3 25 | $1.2B | $490.2M | ||
| Q2 25 | $1.1B | $468.6M | ||
| Q1 25 | $1.0B | $453.4M | ||
| Q4 24 | $1.3B | $437.8M | ||
| Q3 24 | $1.3B | $420.8M | ||
| Q2 24 | $1.2B | $405.8M | ||
| Q1 24 | $1.2B | $389.9M |
总资产LIVNRVLV
| Q4 25 | $2.6B | $765.0M | ||
| Q3 25 | $2.6B | $751.3M | ||
| Q2 25 | $2.5B | $722.9M | ||
| Q1 25 | $2.6B | $713.9M | ||
| Q4 24 | $2.5B | $665.5M | ||
| Q3 24 | $2.5B | $670.9M | ||
| Q2 24 | $2.5B | $657.8M | ||
| Q1 24 | $2.5B | $650.0M |
负债/权益比LIVNRVLV
| Q4 25 | 0.31× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.38× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | 0.47× | — | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.50× | — | ||
| Q1 24 | 0.51× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.4M | $-10.2M |
| 自由现金流经营现金流 - 资本支出 | $50.2M | $-13.3M |
| 自由现金流率自由现金流/营收 | 13.9% | -4.1% |
| 资本支出强度资本支出/营收 | 8.9% | 1.0% |
| 现金转化率经营现金流/净利润 | 2.67× | -0.55× |
| 过去12个月自由现金流最近4个季度 | $173.3M | $48.0M |
8季度趋势，按日历期对齐
经营现金流LIVNRVLV
| Q4 25 | $82.4M | $-10.2M | ||
| Q3 25 | $85.1M | $11.8M | ||
| Q2 25 | $62.9M | $12.6M | ||
| Q1 25 | $24.0M | $45.1M | ||
| Q4 24 | $78.7M | $3.9M | ||
| Q3 24 | $51.0M | $9.1M | ||
| Q2 24 | $43.4M | $-24.7M | ||
| Q1 24 | $10.0M | $38.4M |
自由现金流LIVNRVLV
| Q4 25 | $50.2M | $-13.3M | ||
| Q3 25 | $62.2M | $7.5M | ||
| Q2 25 | $47.8M | $10.4M | ||
| Q1 25 | $13.2M | $43.4M | ||
| Q4 24 | $68.3M | $2.1M | ||
| Q3 24 | $32.8M | $8.0M | ||
| Q2 24 | $31.2M | $-25.7M | ||
| Q1 24 | $3.6M | $36.7M |
自由现金流率LIVNRVLV
| Q4 25 | 13.9% | -4.1% | ||
| Q3 25 | 17.4% | 2.5% | ||
| Q2 25 | 13.6% | 3.4% | ||
| Q1 25 | 4.2% | 14.6% | ||
| Q4 24 | 21.2% | 0.7% | ||
| Q3 24 | 10.3% | 2.8% | ||
| Q2 24 | 9.8% | -9.1% | ||
| Q1 24 | 1.2% | 13.5% |
资本支出强度LIVNRVLV
| Q4 25 | 8.9% | 1.0% | ||
| Q3 25 | 6.4% | 1.5% | ||
| Q2 25 | 4.3% | 0.7% | ||
| Q1 25 | 3.4% | 0.6% | ||
| Q4 24 | 3.2% | 0.6% | ||
| Q3 24 | 5.7% | 0.4% | ||
| Q2 24 | 3.8% | 0.4% | ||
| Q1 24 | 2.2% | 0.6% |
现金转化率LIVNRVLV
| Q4 25 | 2.67× | -0.55× | ||
| Q3 25 | 3.18× | 0.56× | ||
| Q2 25 | 2.32× | 1.24× | ||
| Q1 25 | — | 3.82× | ||
| Q4 24 | 1.41× | 0.32× | ||
| Q3 24 | 1.55× | 0.83× | ||
| Q2 24 | 2.65× | -1.60× | ||
| Q1 24 | — | 3.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LIVN
| Other | $169.4M | 47% |
| Neuromodulation Segment | $119.7M | 33% |
| Cardiopulmonary Segment | $71.8M | 20% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
